• 1. Synthesis and analysis of stable isotope-labelled N-acyl homoserine lactones
  Ewout Ruysbergh,Christian V. Stevens,Norbert De Kimpe,Sven Mangelinckx RSC Adv. 2016 6 73717
• 2. Cascade enzymatic synthesis of l-homoserine – mathematical modelling as a tool for process optimisation and design
  M. ?esnik,M. Sudar,K. Hernández,S. Charnock,?. Vasi?-Ra?ki,P. Clapés,Z. Findrik Bla?evi? React. Chem. Eng. 2020 5 747
• 3. A single site mutation can induce functional promiscuity in homoserine kinase
  Ankita Tripathi,Kshatresh Dutta Dubey Org. Biomol. Chem. 2023 21 4648
• 4. Quorum sensing and bacterial biofilms
  Jeroen S. Dickschat Nat. Prod. Rep. 2010 27 343
• 5. Rational design and synthesis of new quorum-sensing inhibitors derived from acylated homoserine lactones and natural products from garlic
  Tobias Persson,Thomas H. Hansen,Thomas B. Rasmussen,Mette E. Skinders?,Michael Givskov,John Nielsen Org. Biomol. Chem. 2005 3 253

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives L-alpha-amino acids
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Professional Introduction to L-Homoserine (CAS No. 672-15-1)

L-Homoserine, a crucial alpha-amino acid derivative, is widely recognized for its significant role in biochemical pathways and nutritional supplements. With the chemical formula C?H??NO? and the CAS number 672-15-1, this compound has garnered considerable attention in the fields of pharmaceutical research, enzymology, and metabolic studies. Its structural similarity to other essential amino acids makes it a key intermediate in the synthesis of various biologically important molecules.

The L-form of homoserine is particularly notable for its involvement in the biosynthesis of essential amino acids such as methionine and threonine. This process is facilitated by the enzyme homoserine kinase, which catalyzes the phosphorylation of homoserine to form homoserine lactone, a precursor in the methionine biosynthetic pathway. Recent advancements in genetic engineering and microbial fermentation have enabled the efficient production of L-homoserine, making it more accessible for industrial and research applications.

In recent years, researchers have explored the potential of L-homoserine as a nutraceutical agent due to its ability to support protein synthesis and enhance muscle recovery. Studies have demonstrated that supplementation with L-homoserine can improve nitrogen retention and promote muscle growth, particularly in athletes and individuals undergoing intense physical training. Additionally, its role in maintaining optimal liver function has been highlighted, as it aids in the detoxification processes and supports the production of essential enzymes.

The compound's significance extends to neurological research, where it has been implicated in the synthesis of neurotransmitters such as GABA (gamma-aminobutyric acid). Emerging evidence suggests that L-homoserine may modulate neuronal activity and contribute to cognitive health. Furthermore, its potential application in treating neurodegenerative diseases is under investigation, with preliminary studies indicating its ability to protect against oxidative stress and neurotoxicity.

From a synthetic chemistry perspective, L-homoserine serves as a versatile building block for the development of novel pharmaceuticals. Its structural framework allows for modifications that can enhance drug efficacy and reduce side effects. For instance, derivatives of L-homoserine have been investigated for their antimicrobial properties, offering promising candidates for combating resistant bacterial strains. The compound's role in peptidomimetics and protease inhibitors also underscores its importance in drug discovery.

The industrial production of L-homoserine has seen significant advancements due to innovations in biocatalysis and process optimization. Microbial strains such as *Escherichia coli* and *Saccharomyces cerevisiae* have been engineered to overproduce L-homoserine through metabolic engineering strategies. These developments have not only improved yield but also reduced production costs, making it more feasible for large-scale applications. The compound's compatibility with various purification techniques further enhances its industrial viability.

Environmental considerations have also driven research into sustainable methods for producing L-homoserine. Researchers are exploring bio-based production systems that minimize waste and energy consumption. Additionally, the compound's potential as a precursor for biodegradable polymers is being explored, aligning with global efforts to develop eco-friendly materials. These initiatives highlight the compound's broader impact beyond traditional pharmaceuticals.

The regulatory landscape for L-homoserine is well-established, with agencies such as the FDA and EMA providing guidelines for its use in food supplements and pharmaceuticals. Its safety profile has been thoroughly evaluated through extensive toxicological studies, reinforcing its suitability for human consumption. This regulatory confidence has encouraged further investment in research and development, ensuring that new applications are thoroughly validated before commercialization.

Future directions in L-homoserine research are likely to focus on expanding its therapeutic applications and optimizing production methods. Advances in gene editing technologies may enable more precise modifications of metabolic pathways, leading to higher yields of high-purity L-homoserine. Furthermore, interdisciplinary collaborations between chemists, biologists, and pharmacologists will be crucial in unlocking the full potential of this versatile compound.

• 617-45-8(2-aminobutanedioic acid)
• 119736-88-8(L-Homoserine)
• 6027-21-0(D-Homoserine)
• 1783-96-6(D-Aspartic acid)
• 14341-75-4(DL-Aspartic-2,3,3-d3 Acid)
• 25608-40-6(Polyaspartic Acid)
• 1927-25-9(2-amino-4-hydroxybutanoic acid)
• 498-19-1(tert-butyl-m-xylene)
• 56-84-8(L-Aspartic acid)
• 145224-96-0(hexaaspartic acid)